menu search

Amylyx pharmaceuticals's als dug rejected again by eu regulators

Amylyx Pharmaceuticals shares fell Friday after its ALS (amyotrophic lateral sclerosis) drug was denied marketing authorization by European Union regu...

October 13, 2023, 11:38 am

Amylyx pharmaceuticals shares fall after als treatment is rejected by european regulator

Amylyx Pharmaceuticals Inc. AMLX, -4.60% shares fell 7.5% premarket on Friday after the company said the European Medicines Agency had confirmed its n...

October 13, 2023, 8:31 am

Eu regulator declines to recommend amylyx' als drug

Amylyx Pharmaceuticals said on Friday the European Union medicines regulator for the second time declined to recommend a marketing authorisation for t...

October 13, 2023, 8:28 am

Eu regulator backs pfizer's blood cancer therapy

The European Union medicines regulator on Friday recommended a conditional marketing authorization for U.S. drugmaker Pfizer's therapy for a type of b...

October 13, 2023, 8:05 am

Ardelyx to present data updates for xphozah (tenapanor) for hyperphosphatemia at kidney week 2023 november 1-5 in philadelphia, pa

WALTHAM, Mass., Oct. 13, 2023 (GLOBE NEWSWIRE) -- Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company founded with a mission to discover, develo...

October 13, 2023, 8:00 am

Class-action accuses kenvue, inc. (kvue) of not disclosing known commercial risks to cold medicine drugs, says hagens berman, national trial attorneys

Firm Encourages Kenvue (KVUE) Investors with Substantial Losses to Contact its Attorneys SAN FRANCISCO, Oct. 12, 2023 (GLOBE NEWSWIRE) — Hagens Berm...

October 12, 2023, 11:27 pm

Nanoviricides, inc. to present at the partnership opportunities in drug delivery conference in boston on october 16, 2023 at 6:07pm et

SHELTON, CT / ACCESSWIRE / October 12, 2023 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), announces that the Company's President, Dr. An...

October 12, 2023, 6:45 am

Ozempic study shakes up market for kidney and insulin treatments

American depositary receipts (ADRs) of Novo Nordisk (NOVO) jumped over 6% in early trading on Wednesday, while shares of kidney dialysis machine and i...

October 11, 2023, 1:05 pm

Electrocore expands intellectual property portfolio for non-invasive vagus nerve stimulation (nvns) technology

ROCKAWAY, N.J., Oct. 11, 2023 (GLOBE NEWSWIRE) — electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic ...

October 11, 2023, 12:00 pm

Vivos therapeutics to kick off clinical trial at stanford medicine

Vivos Therapeutics (NASDAQ:VVOS) Inc has announced that its flagship daytime-nighttime appliance (DNA) will be tested in a clinical trial at Stanford ...

October 11, 2023, 8:29 am

Bridgebio pharma announces new england journal of medicine publication of positive encaleret proof-of-concept phase 2b results in patients with autosomal dominant hypocalcemia type 1 (adh1)

– In our study, encaleret restored physiologic mineral homeostasis in 13 participants with ADH1, specifically correcting hypocalcemia and reducing h...

October 10, 2023, 11:30 am

Annexon announces clinical and regulatory progress for anx005 pivotal program in guillain-barré syndrome (gbs)

ANX005 Granted Orphan Drug Designation by the European Medicines Agency for the Treatment of GBS Target Enrollment Achieved in Phase 3 Pivotal Study o...

October 10, 2023, 10:30 am

Connected drug delivery devices market set to reach usd 2,980.9 million by 2032, fueled by personalized medicine trends

The rising popularity of connected drug delivery devices is driving the growth in demand for home healthcare. These devices provide convenience and us...

October 9, 2023, 1:38 pm

Bicycle health commends u.s. drug enforcement administration as it extends telemedicine rule through the end of 2024

This decision will continue to protect thousands of patients across the U.S. who access care for opioid use disorder via clinically proven virtual car...

October 6, 2023, 10:00 pm

Should you sell this stock after another regulatory headwind?

Eli Lilly set out to launch four new products this year, but it is unlikely to do so. The company's regulatory roadblocks aren't deal-breakers for its...

October 6, 2023, 6:09 am

Infinity pharmaceuticals, inc. investors: lead plaintiff deadline is approaching in the class action against infinity pharmaceuticals, inc.; contact robbins llp today

SAN DIEGO, Oct. 05, 2023 (GLOBE NEWSWIRE) — Robbins LLP reminds investors that a shareholder filed a class action on behalf of persons and entities ...

October 5, 2023, 7:18 pm

Miromatrix ceo jeff ross to present at the 2023 cell & gene meeting on the mesa

EDEN PRAIRIE, Minn., Oct. 05, 2023 (GLOBE NEWSWIRE) -- Miromatrix Medical Inc. (NASDAQ: MIRO), a life sciences company pioneering a novel technology f...

October 5, 2023, 4:30 pm

Investing in moderna: a speculative buy for long-term gains

Moderna is a biotech company with high potential upside, despite the decline in demand for its COVID-19 vaccine. The company's mRNA platform approach ...

October 5, 2023, 3:21 pm

Wegovy class has higher gi side effect risk than older weight loss drug in study

Medicines in the same class as Novo Nordisk's popular weight-loss therapy Wegovy may carry an increased risk of pancreatitis, intestinal blockage, and...

October 5, 2023, 2:31 pm

3 unstoppable robotics stocks that will make early investors rich

Robotics does not necessarily have to look like in the movies, where you have a janitor in the house who makes your meals, washes your dishes, and bri...

October 5, 2023, 8:16 am


Search within

Pages Search Results: